N-(4-acetylphenyl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-[4-[[2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetyl]amino]phenyl]methanimine oxide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-ethoxyphenyl)acetamide;bis(2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-methylphenyl)acetamide);2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-naphthalen-2-ylacetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-phenylacetamide

C116H118N36O24 — CID 162184090

IUPACN-(4-acetylphenyl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-[4-[[2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetyl]amino]phenyl]methanimine oxide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-ethoxyphenyl)acetamide;bis(2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-methylphenyl)acetamide);2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-naphthalen-2-ylacetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-phenylacetamide
SMILESC=[N+]([O-])c1ccc(NC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)cc1.CC(=O)c1ccc(NC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)cc1.CCOc1ccc(NC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)cc1.Cc1ccc(NC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)cc1.Cc1ccc(NC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)cc1.Cn1c(=O)c2c(ncn2CC(=O)Nc2ccc3ccccc3c2)n(C)c1=O.Cn1c(=O)c2c(ncn2CC(=O)Nc2ccccc2)n(C)c1=O
InChIInChI=1S/C19H17N5O3.C17H17N5O4.C17H19N5O4.C16H16N6O4.2C16H17N5O3.C15H15N5O3/c1-22-17-16(18(26)23(2)19(22)27)24(11-20-17)10-15(25)21-14-8-7-12-5-3-4-6-13(12)9-14;1-10(23)11-4-6-12(7-5-11)19-13(24)8-22-9-18-15-14(22)16(25)21(3)17(26)20(15)2;1-4-26-12-7-5-11(6-8-12)19-13(23)9-22-10-18-15-14(22)16(24)21(3)17(25)20(15)2;1-19-14-13(15(24)20(2)16(19)25)22(9-17-14)8-12(23)18-10-4-6-11(7-5-10)21(3)26;2*1-10-4-6-11(7-5-10)18-12(22)8-21-9-17-14-13(21)15(23)20(3)16(24)19(14)2;1-18-13-12(14(22)19(2)15(18)23)20(9-16-13)8-11(21)17-10-6-4-3-5-7-10/h3-9,11H,10H2,1-2H3,(H,21,25);4-7,9H,8H2,1-3H3,(H,19,24);5-8,10H,4,9H2,1-3H3,(H,19,23);4-7,9H,3,8H2,1-2H3,(H,18,23);2*4-7,9H,8H2,1-3H3,(H,18,22);3-7,9H,8H2,1-2H3,(H,17,21)
InChIKeyKXWLLOHGHAXHJI-UHFFFAOYSA-N
MW2400.45 g/mol
LogP2.72
Rot. Bonds25

About N-(4-acetylphenyl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-[4-[[2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetyl]amino]phenyl]methanimine oxide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-ethoxyphenyl)acetamide;bis(2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-methylphenyl)acetamide);2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-naphthalen-2-ylacetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-phenylacetamide

N-(4-acetylphenyl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-[4-[[2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetyl]amino]phenyl]methanimine oxide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-ethoxyphenyl)acetamide;bis(2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-methylphenyl)acetamide);2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-naphthalen-2-ylacetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-phenylacetamide (PubChem CID 162184090) has the molecular formula C116H118N36O24 and a molecular weight of 2400.45 g/mol. Its IUPAC name is N-(4-acetylphenyl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-[4-[[2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetyl]amino]phenyl]methanimine oxide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-ethoxyphenyl)acetamide;bis(2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-methylphenyl)acetamide);2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-naphthalen-2-ylacetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-phenylacetamide.

Molecular Properties

Compound NameN-(4-acetylphenyl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-[4-[[2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetyl]amino]phenyl]methanimine oxide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-ethoxyphenyl)acetamide;bis(2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-methylphenyl)acetamide);2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-naphthalen-2-ylacetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-phenylacetamide
PubChem CID162184090
Molecular FormulaC116H118N36O24
Molecular Weight2400.45 g/mol
Exact Mass2398.91
IUPAC NameN-(4-acetylphenyl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-[4-[[2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetyl]amino]phenyl]methanimine oxide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-ethoxyphenyl)acetamide;bis(2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-methylphenyl)acetamide);2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-naphthalen-2-ylacetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-phenylacetamide
SMILESC=[N+]([O-])c1ccc(NC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)cc1.CC(=O)c1ccc(NC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)cc1.CCOc1ccc(NC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)cc1.Cc1ccc(NC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)cc1.Cc1ccc(NC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)cc1.Cn1c(=O)c2c(ncn2CC(=O)Nc2ccc3ccccc3c2)n(C)c1=O.Cn1c(=O)c2c(ncn2CC(=O)Nc2ccccc2)n(C)c1=O
InChIInChI=1S/C19H17N5O3.C17H17N5O4.C17H19N5O4.C16H16N6O4.2C16H17N5O3.C15H15N5O3/c1-22-17-16(18(26)23(2)19(22)27)24(11-20-17)10-15(25)21-14-8-7-12-5-3-4-6-13(12)9-14;1-10(23)11-4-6-12(7-5-11)19-13(24)8-22-9-18-15-14(22)16(25)21(3)17(26)20(15)2;1-4-26-12-7-5-11(6-8-12)19-13(23)9-22-10-18-15-14(22)16(24)21(3)17(25)20(15)2;1-19-14-13(15(24)20(2)16(19)25)22(9-17-14)8-12(23)18-10-4-6-11(7-5-10)21(3)26;2*1-10-4-6-11(7-5-10)18-12(22)8-21-9-17-14-13(21)15(23)20(3)16(24)19(14)2;1-18-13-12(14(22)19(2)15(18)23)20(9-16-13)8-11(21)17-10-6-4-3-5-7-10/h3-9,11H,10H2,1-2H3,(H,21,25);4-7,9H,8H2,1-3H3,(H,19,24);5-8,10H,4,9H2,1-3H3,(H,19,23);4-7,9H,3,8H2,1-2H3,(H,18,23);2*4-7,9H,8H2,1-3H3,(H,18,22);3-7,9H,8H2,1-2H3,(H,17,21)
InChIKeyKXWLLOHGHAXHJI-UHFFFAOYSA-N
XLogP2.72
TPSA688.81 Ų
H-Bond Donors7
H-Bond Acceptors52
Rotatable Bonds25
Heavy Atoms176
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002400.45
LogP ≤ 52.72
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1052

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'}

Analyze N-(4-acetylphenyl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-[4-[[2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetyl]amino]phenyl]methanimine oxide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-ethoxyphenyl)acetamide;bis(2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-methylphenyl)acetamide);2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-naphthalen-2-ylacetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-phenylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-(4-acetylphenyl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-[4-[[2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetyl]amino]phenyl]methanimine oxide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-ethoxyphenyl)acetamide;bis(2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-methylphenyl)acetamide);2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-naphthalen-2-ylacetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-phenylacetamide?
The IUPAC name of N-(4-acetylphenyl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-[4-[[2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetyl]amino]phenyl]methanimine oxide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-ethoxyphenyl)acetamide;bis(2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-methylphenyl)acetamide);2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-naphthalen-2-ylacetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-phenylacetamide (CID 162184090) is N-(4-acetylphenyl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-[4-[[2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetyl]amino]phenyl]methanimine oxide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-ethoxyphenyl)acetamide;bis(2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-methylphenyl)acetamide);2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-naphthalen-2-ylacetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-phenylacetamide.
What is the SMILES notation for N-(4-acetylphenyl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-[4-[[2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetyl]amino]phenyl]methanimine oxide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-ethoxyphenyl)acetamide;bis(2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-methylphenyl)acetamide);2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-naphthalen-2-ylacetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-phenylacetamide?
The canonical SMILES for N-(4-acetylphenyl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-[4-[[2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetyl]amino]phenyl]methanimine oxide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-ethoxyphenyl)acetamide;bis(2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-methylphenyl)acetamide);2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-naphthalen-2-ylacetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-phenylacetamide is C=[N+]([O-])c1ccc(NC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)cc1.CC(=O)c1ccc(NC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)cc1.CCOc1ccc(NC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)cc1.Cc1ccc(NC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)cc1.Cc1ccc(NC(=O)Cn2cnc3c2c(=O)n(C)c(=O)n3C)cc1.Cn1c(=O)c2c(ncn2CC(=O)Nc2ccc3ccccc3c2)n(C)c1=O.Cn1c(=O)c2c(ncn2CC(=O)Nc2ccccc2)n(C)c1=O.
What is the InChIKey of N-(4-acetylphenyl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-[4-[[2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetyl]amino]phenyl]methanimine oxide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-ethoxyphenyl)acetamide;bis(2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-methylphenyl)acetamide);2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-naphthalen-2-ylacetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-phenylacetamide?
The InChIKey is KXWLLOHGHAXHJI-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H17N5O3.C17H17N5O4.C17H19N5O4.C16H16N6O4.2C16H17N5O3.C15H15N5O3/c1-22-17-16(18(26)23(2)19(22)27)24(11-20-17)10-15(25)21-14-8-7-12-5-3-4-6-13(12)9-14;1-10(23)11-4-6-12(7-5-11)19-13(24)8-22-9-18-15-14(22)16(25)21(3)17(26)20(15)2;1-4-26-12-7-5-11(6-8-12)19-13(23)9-22-10-18-15-14(22)16(24)21(3)17(25)20(15)2;1-19-14-13(15(24)20(2)16(19)25)22(9-17-14)8-12(23)18-10-4-6-11(7-5-10)21(3)26;2*1-10-4-6-11(7-5-10)18-12(22)8-21-9-17-14-13(21)15(23)20(3)16(24)19(14)2;1-18-13-12(14(22)19(2)15(18)23)20(9-16-13)8-11(21)17-10-6-4-3-5-7-10/h3-9,11H,10H2,1-2H3,(H,21,25);4-7,9H,8H2,1-3H3,(H,19,24);5-8,10H,4,9H2,1-3H3,(H,19,23);4-7,9H,3,8H2,1-2H3,(H,18,23);2*4-7,9H,8H2,1-3H3,(H,18,22);3-7,9H,8H2,1-2H3,(H,17,21).
What are the key properties of N-(4-acetylphenyl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-[4-[[2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetyl]amino]phenyl]methanimine oxide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-ethoxyphenyl)acetamide;bis(2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-methylphenyl)acetamide);2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-naphthalen-2-ylacetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-phenylacetamide?
N-(4-acetylphenyl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-[4-[[2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetyl]amino]phenyl]methanimine oxide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-ethoxyphenyl)acetamide;bis(2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-methylphenyl)acetamide);2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-naphthalen-2-ylacetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-phenylacetamide has a molecular weight of 2400.45 g/mol, XLogP of 2.72, 25 rotatable bonds, 7 hydrogen bond donors, and 52 hydrogen bond acceptors.
Where does this data come from?
All data for N-(4-acetylphenyl)-2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetamide;N-[4-[[2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetyl]amino]phenyl]methanimine oxide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-ethoxyphenyl)acetamide;bis(2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(4-methylphenyl)acetamide);2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-naphthalen-2-ylacetamide;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-phenylacetamide is sourced from PubChem (CID 162184090), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).